Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$74.18 - $108.93 $1.04 Million - $1.52 Million
-13,997 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$63.18 - $85.97 $180,505 - $245,616
2,857 Added 25.65%
13,997 $1.03 Million
Q4 2019

Feb 14, 2020

BUY
$73.04 - $95.72 $7,011 - $9,189
96 Added 0.87%
11,140 $973,000
Q3 2019

Nov 13, 2019

SELL
$72.82 - $86.52 $2.67 Million - $3.17 Million
-36,653 Reduced 76.85%
11,044 $820,000
Q2 2019

Aug 14, 2019

BUY
$73.52 - $88.7 $1.23 Million - $1.49 Million
16,742 Added 54.08%
47,697 $4.05 Million
Q1 2019

May 15, 2019

SELL
$63.56 - $88.17 $309,219 - $428,947
-4,865 Reduced 13.58%
30,955 $2.66 Million
Q4 2018

Feb 13, 2019

SELL
$58.5 - $69.94 $351,234 - $419,919
-6,004 Reduced 14.36%
35,820 $2.28 Million
Q3 2018

Nov 13, 2018

SELL
$61.75 - $74.23 $2.47 Million - $2.97 Million
-39,952 Reduced 48.86%
41,824 $2.89 Million
Q2 2018

Aug 14, 2018

BUY
$60.85 - $83.98 $1.09 Million - $1.5 Million
17,912 Added 28.05%
81,776 $5.48 Million
Q1 2018

May 15, 2018

BUY
$83.06 - $100.98 $3.24 Million - $3.93 Million
38,951 Added 156.35%
63,864 $5.32 Million
Q4 2017

Feb 13, 2018

BUY
$93.56 - $116.6 $448,807 - $559,330
4,797 Added 23.85%
24,913 $2.36 Million
Q3 2017

Nov 13, 2017

BUY
$109.15 - $138.27 $2.2 Million - $2.78 Million
20,116
20,116 $2.35 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track University Of Notre Dame Du Lac Portfolio

Follow University Of Notre Dame Du Lac and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of University Of Notre Dame Du Lac, based on Form 13F filings with the SEC.

News

Stay updated on University Of Notre Dame Du Lac with notifications on news.